Objective Interleukin‐6 (IL‐6) is a pleiotropic cytokine that regulates the immune response,
inflammation, and hematopoiesis. Overproduction of IL‐6 plays pathologic roles in …

The signalling pathway that comprises JAK kinases and STAT proteins (for signal transducer
and activator of transcription) is important for relaying signals from various cytokines …

Castleman's disease is a syndrome consisting of giant lymph node hyperplasia with plasma
cell infiltration, fever, anemia, hypergammaglobulinemia, and an increase in the plasma …

Multicentric Castleman disease (MCD) is an atypical lymphoproliferative disorder characterized
by systemic lymphadenopathy and constitutional inflammatory symptoms. Dysregulated …

Alterations of TGF-β signaling have been described in colorectal cancer, although the molecular
consequences are largely unknown. By using transgenic mice overexpressing TGF-β or …

Background & Aims: Interleukin-6 (IL-6) regulates immune response and inflammation. We
carried out a pilot placebo-controlled study to investigate the efficacy, pharmacokinetics, and …

Castleman's disease, an atypical lymphoproliferative disorder, can be classified into 2 types:
hyaline-vascular and plasma cell types according to the histologic features of the affected …

Objective To investigate the safety and efficacy of a recombinant human anti–interleukin‐6 (anti–IL‐6)
receptor monoclonal antibody (MRA) that indirectly inhibits the effects of IL‐6 in …

Objective To investigate whether interleukin‐6 (IL‐6) is a regulator of vascular endothelial
growth factor (VEGF) in rheumatoid arthritis (RA). Methods Serum VEGF levels in RA patients …

Proinflammatory cytokines have been demonstrated to play a crucial role in the pathogenesis
of Crohn’s disease. Among those cytokines, strong expression of IL-6 has been repeatedly …